46. 悪性関節リウマチ Malignant rheumatoid arthritis Clinical trials / Disease details

臨床試験数 : 4,325 / 薬物数 : 2,671 - (DrugBank : 417) / 標的遺伝子数 : 187 - 標的パスウェイ数 : 224

1238 trials found

diseases per page:

Showing 1 to 10 of 1,238 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05166304 (ClinicalTrials.gov)	April 2022	8/12/2021	Rebamipide in Patients With Active Rheumatoid Arthritis	Rebamipide as an Adjunct to Methotrexate in Patients With Active Rheumatoid Arthritis	Rheumatoid Arthritis	Drug: Rebamipide;Drug: Placebo	October 6 University	NULL	Not yet recruiting	18 Years	60 Years	All	100	Phase 1/Phase 2	NULL
2	NCT05264025 (ClinicalTrials.gov)	April 2022	10/1/2022	Fexofenadine in Patients With Active Rheumatoid Arthritis	Fexofenadine as Adjunct to Standard Rheumatoid Therapy in Patients With Active Rheumatoid	Rheumatoid Arthritis	Drug: Fexofenadine;Drug: Placebo	October 6 University	NULL	Not yet recruiting	18 Years	60 Years	All	80	Phase 1/Phase 2	NULL
3	NCT05238896 (ClinicalTrials.gov)	March 1, 2022	4/1/2022	BARIcitinib Cognitive Emotional and Neural signaTuRE	BARIcitinib Cognitive Emotional and Neural signaTuRE (BARICENTRE)	Rheumatoid Arthritis	Drug: Baricitinib Oral Tablet [Olumiant];Drug: Placebo	Assistance Publique - Hôpitaux de Paris	NULL	Not yet recruiting	18 Years	75 Years	All	80	Phase 4	France
4	EUCTR2021-004131-84-NL (EUCTR)	14/02/2022	08/09/2021	Comparing the effectiveness of tofacitinib extended release (XR) chronotherapy, morning versus eveni ...	Chronotherapy in Inflammatory Arthritis (ChronIA trial): a crossover randomized controlled trial com ...	Rheumatoid arthritis or psoriatic arthritis according to respectively 2010 criteria or CASPAR criter ...	Trade Name: Xeljanz XR Product Name: Tofacitinib XR Product Code: EMEA/H/C/004214	Erasmus Medical Center	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	84	Phase 4	Netherlands
5	NCT04688398 (ClinicalTrials.gov)	January 10, 2022	14/12/2020	Study of the Impact of Fatty Acids From Seal Oil on the Relief of Symptoms Associated With Rheumatoi ...	Study of the Impact of Fatty Acids From Seal Oil on the Relief of Symptoms Associated With Rheumatoi ...	Polyarthritis	Dietary Supplement: Seal oil;Dietary Supplement: Control	Laval University	Ministry of Agriculture, Fisheries and Food, Quebec;Groupe De Recherche En Rhumatologie Et Maladies ...	Not yet recruiting	18 Years	N/A	All	130	N/A	NULL
6	NCT04924270 (ClinicalTrials.gov)	January 2022	7/6/2021	Safety and Efficacy of Faecal Microbiota Transplantation in Treatment-naïve Patients With Newly Diag ...	Safety and Clinical Efficacy Associated With Faecal Microbiota Transplantation Performed in Treatmen ...	Rheumatoid Arthritis;Reactive Arthritis;Ankylosing Spondylitis;Psoriatic Arthritis;Gouty Arthritis;P ...	Biological: Faecal microbiota transplantation;Other: Placebo	Torkell Ellingsen	Region of Southern Denmark;University of Southern Denmark	Not yet recruiting	18 Years	70 Years	All	200	Phase 2	NULL
7	NCT05124782 (ClinicalTrials.gov)	November 30, 2021	22/10/2021	Virtual Management of Rheumatoid Arthritis	Evaluation of Rheumatoid Arthritis at the Time of Telemedicine	Rheumatoid Arthritis	Other: Rheumatoid Arthritis Impact of Disease questionnaire	Assistance Publique - Hôpitaux de Paris	NULL	Recruiting	N/A	N/A	All	100		France
8	NCT05053165 (ClinicalTrials.gov)	November 12, 2021	16/9/2021	A Study to Assess the Safety and Tolerability of LB-P6 and LB-P8 in Healthy Participants	A Phase 1, Randomised, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, Ph ...	Rheumatoid Arthritis;Non-Alcoholic Steatohepatitis	Drug: LB-P6;Drug: LB-P8;Drug: Placebo	LISCure Biosciences	Novotech (Australia) Pty Limited	Recruiting	18 Years	65 Years	All	30	Phase 1	Australia
9	NCT04985812 (ClinicalTrials.gov)	October 18, 2021	6/7/2021	A Study of JNJ-67484703 in Participants With Active Rheumatoid Arthritis Despite Methotrexate Therap ...	A Multicenter, Double-blind, Placebo-controlled, Randomized, Multiple Dose Study to Assess the Safet ...	Rheumatoid Arthritis	Drug: JNJ-67484703;Drug: Placebo	Janssen Research & Development, LLC	NULL	Recruiting	18 Years	65 Years	All	42	Phase 1	United States;Georgia;Hungary;Moldova, Republic of;Spain;Ukraine
10	NCT05251870 (ClinicalTrials.gov)	August 17, 2021	21/12/2021	Tolerogenic Dendritic Cell Therapy for Rheumatoid Arthritis	Tolerogenic Dendritic Cell Therapy for Rheumatoid Arthritis: the TOLERANT Trial	Rheumatoid Arthritis	Drug: autologous mature tolerogenic monocyte-derived Dendritic Cells loaded with the B29 peptide of ...	UMC Utrecht	Radboud University Medical Center;Utrecht University;Trajectum Pharma B.V.;Dutch Arthritis Associati ...	Recruiting	18 Years	N/A	All	18	Phase 1/Phase 2	Netherlands

First Previous1 2 3 4 5…124Next Last